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Species limits within the clinically important Fusarium incarnatum-F. equiseti and F. chlamydosporum species
complexes (FIESC and FCSC, respectively) were investigated using multilocus DNA sequence data. Maximum-
parsimony and maximum-likelihood analyses of aligned DNA sequences from four loci resolved 28 species
within the FIESC, within which the species were evenly divided among two clades designated Incarnatum and
Equiseti, and four species within the FCSC. Sequence data from a fifth locus, -tubulin, was excluded from the
study due to the presence of highly divergent paralogs or xenologs. The multilocus haplotype nomenclature
adopted in a previous study (K. O’Donnell, D. A. Sutton, A. Fothergill, D. McCarthy, M. G. Rinaldi, M. E.
Brandt, N. Zhang, and D. M. Geiser, J. Clin. Microbiol. 46:2477–2490, 2008) was expanded to all of the species
within the FIESC and FCSC to provide the first DNA sequence-based typing schemes for these fusaria, thereby
facilitating future epidemiological investigations. Multilocus DNA typing identified sixty-two sequence types
(STs) among 88 FIESC isolates and 20 STs among 26 FCSC isolates. This result corresponds to indices of
discrimination of 0.985 and 0.966, respectively, for the FIESC and FCSC four-locus typing scheme using
Simpson’s index of discrimination. Lastly, four human and two veterinary isolates, received as members of the
FIESC or FCSC, were resolved as five phylogenetically distinct species nested outside these species complexes.
To our knowledge, these five species heretofore have not been reported to cause mycotic infections (i.e., F.
armeniacum, F. brachygibbosum, F. flocciferum, and two unnamed Fusarium species within the F. tricinctum
species complex).
Fusarium species are hyaline filamentous molds (Hypocre-
ales, Ascomycota) that can cause superficial infections, such as
onychomycoses and keratitis in immunocompetent individuals,
or deeply invasive and hematogenously disseminated infec-
tions with high mortality in persistently and severely neutro-
penic patients (11). Despite a poor response, liposomal am-
photericin B remains the antifungal of choice for the treatment
of fusarioses (41). Unfortunately, most fusaria exhibit broad
resistance to the spectrum of antifungals currently available,
including amphotericin B, azoles, echinocandins, and terbin-
afine, which typically show high MICs in vitro (1, 2, 35, 41, 43).
Recent multilocus molecular phylogenetic studies have re-
vealed that the most commonly reported fusaria causing infec-
tions in humans and other animals, such as Fusarium solani, F.
oxysporum, and F. moniliforme (F. verticillioides pro parte),
harbor multiple species, several of which are morphologically
cryptic (30, 31, 36). To date, detailed molecular evolutionary
studies have been published on clinically important members
of the F. solani species complex (FSSC) (2, 30, 35, 51), F.
oxysporum species complex (FOSC) (32, 36), Gibberella (Fusar-
ium) fujikuroi species complex (GFSC) (31, 33), and F. di-
merum species complex (FDSC) (44). Species within these four
complexes account for approximately 85% of all fusarioses
within the United States. Members of these complexes are
estimated to cause infections at the following frequencies:
FSSC 60%; FOSC, 10%; GFSC, 10%; and FDSC, 5%. Results
of the present study indicate that the remaining approximately
15% of clinically relevant fusaria from the United States are
mostly nested within two closely related lineages, the F.
chlamydosporum species complex (FCSC) and F. incarna-
tum-F. equiseti species complex (FIESC). Although several
members of the FIESC included in the Centers for Disease
Control and Prevention (CDC) Fusarium keratitis investiga-
tion in 2005 to 2006 were analyzed phylogenetically (8), species
limits within this complex and the FCSC have never been
critically examined employing genealogical concordance phy-
logenetic species recognition (GCPSR) (49) using multilocus
DNA sequence data.
Chang et al. (8) first introduced a multilocus haplotype no-
menclature for members of the FSSC and FOSC involved in
CDC’s Fusarium keratitis investigation, which elucidated their
epidemiology and population structure and facilitated accurate
communication of their genetic diversity within the public
health community. The multilocus species/haplotype nomen-
clature developed for these fusaria is important for accurately
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reporting on pathogen identity and their genetic diversity, pri-
marily because several molecular phylogenetic studies have
revealed that most fusaria pathogenic to humans and other
animals lack Latin binomials (5, 34, 35, 44, 51). In the present
study, species limits and evolutionary relationships within the
FCSC and FIESC were investigated via GCPSR for the first
time using DNA sequence data from portions of four loci. In
addition, we report on five Fusarium species that to our knowl-
edge have not been reported previously to cause infections of
humans or other animals.
MATERIALS AND METHODS
Fungal isolates. Eighty-eight of the 120 isolates included in this study (Tables
1 and 2) were cultured from human or veterinary sources. The remaining 32
isolates were chosen to represent the phylogenetic breadth of the FIESC and
FCSC represented within the culture collections of the Centraalbureau voor
Schimmelcultures (CBS) Biodiversity Center (Utrecht, The Netherlands) and
the Fusarium Research Center (FRC, Pennsylvania State University, State Col-
lege, PA). With the exception of six clinical or veterinary isolates and the
outgroup sequences of Fusarium concolor NRRL 13459 (received as the ex-type
strain of F. polyphialidicum, which is a later synonym of F. concolor), the remain-
ing isolates were members of the FCSC or FIESC. The 26 FCSC and 88 FIESC
isolates were identified as members of these two species complexes via morpho-
logical analysis at the respective culture collections (Tables 1 and 2) and subse-
quent molecular phylogenetic analyses of aligned partial sequences of the RNA
polymerase second largest subunit (RPB2) (34). All isolates are stored cryogen-
ically in liquid nitrogen vapor (175°C) in the Agricultural Research Service
(NRRL) Culture Collection, National Center for Agricultural Utilization Re-
search, Peoria, IL, where they are available upon request.
DNA manipulations for multilocus DNA sequencing. Mycelium was grown in
yeast extract-malt broth (20 g of dextrose, 5 g of peptone, 3 g of yeast extract, and
3 g of malt extract per liter; Difco, Detroit, MI) on a rotary shaker at 100 rpm for
2 to 3 days and freeze dried, and then total genomic DNA was extracted using a
hexadecyltrimethyl-ammonium bromide (Sigma, St. Louis, MO) protocol as pre-
viously described (31). Portions of five nuclear gene fragments were selected for
multilocus sequence typing (MLST) based on previous analyses (33–35): trans-
lation elongation factor (EF-1), RPB2, the internal transcribed spacer (ITS)
region, domains D1 and D2 of the nuclear large-subunit (LSU) rRNA, calmod-
ulin (CAM), and -tubulin. Data obtained from this last locus, however, was
excluded from the study due to the presence of highly divergent paralogs (ho-
mologs evolved by gene duplication) or xenologs (homologs evolved by lateral
gene transfer among different species) that complicated phylogenetic reconstruc-
tion. PCR and sequencing primers for the MLST scheme have been published
previously (34, 35). All PCRs employed Platinum Taq DNA polymerase (Invitro-
gen Life Technologies, Carlsbad, CA) and identical cycling parameters in an
Applied Biosystems 9700 Thermocycler (Emeryville, CA), as previously reported
(31). Applied Biosystems BigDye, version 3.1, Terminator reaction mixture was
used in all DNA sequencing reactions (31).
Chromatograms were edited and aligned with Sequencher, version 4.1.2 (Gene
Codes, Ann Arbor, MI), prior to manual improvement of the alignments to
establish positional homology.
Phylogenetic analysis. Maximum-parsimony (MP) analyses implemented in
PAUP*, version 4.0b10 (47), and maximum likelihood (ML) employing GARLI
(52) were conducted as previously described (35), except that nonparametric ML
bootstrapping was conducted with a 2.6-Ghz MacBook Pro. The Akaike infor-
mation criterion in MrModeltest, version 2.2 (29), was used to identify the
best-fit model of nucleotide substitution for the ML analyses. Multilocus haplo-
types or sequence types (STs) were identified using COLLAPSE, version 1.1
(http://inbio.byu.edu/Faculty/kac/crandall_lab/Computer.html).
Nucleotide sequence accession numbers. The DNA sequences determined in
this study have been deposited in the GenBank under accession numbers
GQ505373 to GQ505852.
RESULTS
Phylogenetic diversity of FIESC clinical isolates. Evolution-
ary relationships and species limits of 52 human or veterinary
isolates, together with 36 nonclinical isolates within the FIESC,
were inferred using multilocus DNA sequence data from four
loci. All of the clinically relevant isolates were from the United
States except for one from an endocarditic patient from Brazil
and the ex-type strain of F. lacertarum, which was isolated from
lizard skin in India (45) (Table 1). Tree statistics and summary
sequence for the individual and combined data sets are pro-
vided in Table 3. The combined data set comprised portions of
the EF-1 gene (717 bp), the ITS plus LSU (ITSLSU) 28S
rRNA gene (1,135 bp), RPB2 (1,766 bp), and CAM (704 bp),
totaling 4,322 bp of aligned nucleotide sequence data from
each isolate. Analyses of the individual partitions revealed that
the EF-1 and ITSLSU 28S rRNA genes were the most and
least phylogenetically informative loci, respectively, based on
parsimony-informative characters per bp and number of spe-
cies resolved as monophyletic by MP bootstrapping of the four
individual data sets (Table 3). Results of these analyses re-
solved the 21 FIESC species represented by two or more iso-
lates as reciprocally monophyletic in the majority of the boot-
strapped individual genealogies, thereby fulfilling a stringent
interpretation of species recognition under GCPSR. The re-
maining seven putatively phylogenetically distinct FIESC spe-
cies were each represented by a single highly divergent isolate,
and therefore additional sampling is required to fully assess
their species limits.
To determine whether DNA sequence data from the various
gene partitions could be concatenated into a single data set, an
MP bootstrap value of 70% was used as a threshold for
identifying topological incongruence. Results of these analyses
indicated that the individual data sets could be combined and
analyzed phylogenetically using MP in PAUP* (47) and ML in
GARLI (52). DNA sequence data from a fifth locus, -tubulin,
was excluded from the study due to the widespread presence of
highly divergent paralogs or xenologs. MP and ML phyloge-
netic analyses of the combined data set recovered trees that
were highly concordant topologically (Fig. 1; only the MP tree
is shown) and in which there was a deep basal split between
two early diverging lineages, here informally designated the
Equiseti and Incarnatum clades. The 12 most-parsimonious
trees were 4,322 steps in length; the ML tree with the best
negative log-likelihood score was 15,737.46164 based on 10
independent heuristic analyses, using the general time-revers-
ible (GTR) model of nucleotide substitution with a proportion
of invariant (I) sites and gamma-distributed (G) rate hetero-
geneity (i.e., GTRIG) in GARLI (52). Only relatively mi-
nor differences were observed between the MP and ML topol-
ogies. These differences were restricted to five internodes
along the backbone of the phylogeny within the Incarnatum
clade; however, the MP and ML bootstrap values differed by
only 6 to 11% (Fig. 1). Analyses of the individual and com-
bined partitions support the recognition of 14 phylogenetically
distinct species within each clade. Of the 28 species within the
FIESC, 9 species within the Equiseti clade and 11 within the
Incarnatum clade were recovered from mycotic infections, and
these spanned the phylogenetic breadth of each clade (Fig. 1).
Latin binomials, however, can be applied with confidence to
only three of the species within the Equiseti clade, namely, F.
lacertarum (FIESC 4) (45), F. scirpi (FIESC 9) (7), and F.
equiseti (FIESC 14), and none of the 14 species within the
Incarnatum clade. F. scirpi is broadly circumscribed here to
include two STs from Australia (FIESC 2-a and 2-b) and the
highly divergent NRRL 26922 (FIESC 9-c) from France, which
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TABLE 1. FIESC isolates subjected to DNA MLST
NRRL no. FIESC MLST(species)a Equivalent no(s).
b Isolate source Origin
3020 10-a FRC R-6053, 7.12 MRC Unknown Unknown
3214 10-a FRC R-6054, 7.13 MRC Unknown Unknown
5537 8-a ATCC 28805 Fescue hay Missouri
6548 12-a IMI 112503 Wheat Germany
13335 21-a FRC R-2138 Alfalfa Australia
13379 23-b FRC R-5198, BBA 62200 Oryza sativa India
13402 9-b (F. scirpi) FRC R-6363 Pine soil Australia
13459 (F. concolor)c CBS 691.87 Plant debris South Africa
20423 4-a (F. lacertarum) IMI 300797 Lizard skin India
20697 14-b (F. equiseti) CBS 245.61 Beet Chile
20722 27-a IMI 190455 Chrysanthemum sp. Kenya
22244 25-a H.-K. Chen F64 Rice China
25795 5-c CBS 394.93, BBA 64265 Disphyma crassifolium seed Germany
26417 26-a CBS 544.96 Leaf litter Cuba
26419 14-a (F. equiseti) CBS 307.94, BBA 68556 (neotype) Soil Germany
26921 12-a CBS 731.87 Wheat Germany
26922 9-c (F. scirpi) CBS 610.95 Soil France
28029 3-b CDC B-3335 Human eye California
28577 28-a CBS 430.81 Grave stone Romania
28714 26-b ATCC 74289 Acacia sp. branch Costa Rica
29134 9-a (F. scirpi) CBS 448.84 Pasture soil Australia
31011 12-a BBA 69079 Thuja sp. Germany
31160 15-c MDA 3 Human lung Texas
31167 18-a MDA 10 Human sputum Texas
32175 15-a MDA F10 Human sputum Texas
32181 15-c MDA F20 Human blood Oklahoma
32182 15-b MDA F22 Human blood Texas
32522 18-b Loyola W-14182 Human diabetic cellulitis Illinois
32864 17-a FRC R-7245 Human Texas
32865 21-b FRC R-8480 Human endocarditis Brazil
32866 23-a FRC R-8822 Human cancer patient Texas
32867 23-a FRC R-8837 Human Texas
32868 25-c FRC R-8880 Human blood Texas
32869 15-c FRC R-9445 Human cancer patient Texas
32871 5-a FRC R-9561 Human abscess Texas
32993 25-b UTHSC 00-755 Human nasal tissue Texas
32994 15-c UTHSC 00-494 Human ethmoid sinus Texas
32995 15-c UTHSC 99-1964 Human sinus Texas
32996 15-c UTHSC 99-1741 Human leg wound Texas
32997 7-a UTHSC 99-423 Human toenail Colorado
34001 15-e UTHSC 95-1945 Human foot wound Texas
34002 22-a UTHSC 95-1545 Human ethmoid sinus Texas
34003 20-a UTHSC 95-28 Human sputum Texas
34004 16-a UTHSC 94-2581 Human BAL Texas
34005 24-a UTHSC 94-2471 Human intravitreal fluid Minnesota
34006 15-a UTHSC 93-2692 Human eye Texas
34007 15-a UTHSC 93-933 Human sputum Texas
34008 15-d UTHSC 92-1955 Human lung Texas
34010 15-c UTHSC 02-1698 Human maxillary sinus Texas
34011 15-a UTHSC 02-2060 Human sputum Texas
34032 5-a UTHSC 98-2172 Human abscess Texas
34034 1-c UTHSC 94-1167 Human leg Arizona
34035 5-d UTHSC 91-569 Human sinus Colorado
34037 5-b UTHSC 02-966 Human abscess Colorado
34039 1-b UTHSC 96-1394 Human Connecticut
34056 16-b Loyola M54234 Human bronchial wash Illinois
34059 16-c Loyola S8158 Human blood Illinois
34070 17-c Loyola W37591 Tortoise Illinois
36123 4-b CBS 102300, BBA 70843 Unknown Unknown
36136 14-a (F. equiseti) CBS 107.07, IMI 091982 Unknown Unknown
36269 12-b CBS 162.57 Pinus nigra seedling Croatia
36318 3-a CBS 185.31 Unknown Unknown
36321 14-a (F. equiseti) CBS 185.34 Soil Netherlands
36323 3-a CBS 186.31 Cotton yarn England
36372 11-a CBS 235.79 Air Netherlands Antilles
36392 12-c CBS 259.54 Seedling Germany
36401 2-a CBS 264.50 Cotton Mozambique
Continued on following page
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suggests that additional sampling may reveal that FIESC 9-c
represents a phylogenetically distinct species.
In the absence of our ability to confidently apply Latin bi-
nomials to 25 of the 28 species within the FIESC, the species
and haplotype nomenclature previously adopted within the
medically important clade 3 of the FSSC (35, 51) has been
extended herein to all of the species within the species-rich
FIESC. Results of the typing scheme revealed that, with the
exception of FIESC 10 whose two isolates shared the same ST,
the 20 other species represented by two or more isolates pos-
sessed between two and six STs with unique combinations of
alleles. FIESC 15-a (n  5) and FIESC 15-c (n  8), which
were restricted to Texas and Oklahoma, represented the most
commonly sampled clinically relevant STs in the present study.
Although six species exhibited intercontinental distributions
(i.e., FIESC 3, 4, 9, 14, 23, and 25), FIESC 1-a represented the
only ST out of the 62 unique haplotypes typed in the present
study isolated on separate continents. In addition, FIESC 1-a
and FIESC 6-a were the only two STs within this complex
recovered from humans and other animals (Table 1). Employ-
ing Simpson’s index of diversity, the four-locus FIESC typing
scheme achieved a 0.985 index of discrimination (18).
Phylogenetic diversity of FCSC clinical isolates. Twenty of
the 26 isolates analyzed phylogenetically within the FCSC were
isolated within the United States from mycotic infections, and
they included 19 from humans and a single isolate from a horse
eye. Summary sequence and tree statistics of the four loci
sampled are presented in Table 4. Based on parsimony infor-
mative characters (PIC) per bp (Table 4), CAM and the
ITSLSU 28S rRNA genes were the most and least phyloge-
netically informative loci, respectively, with 0.26 and 0.06 PIC/
bp, respectively. An ambiguously aligned 37-bp indel-contain-
ing region within CAM was excluded from all phylogenetic
analyses. The same conditional combination approach em-
ployed above for the FIESC indicated that trees inferred from
the four FCSC loci sampled represented the same underlying
phylogeny, and therefore the data were analyzed as a com-
bined data set using MP and ML. As noted above, the homo-
plastic distribution of highly divergent -tubulin paralogs or
xenologs precluded the use of this locus for phylogeny recon-
struction. The 12 most-parsimonious trees were 4,299 steps in
length; the ML tree with the best negative log-likelihood score,
using the GTRIG model of nucleotide substitution, was
14,131.69216 based on 10 independent analyses in GARLI
(52). MP and ML phylogenies resolved F. nelsonii as the ear-
liest diverging lineage within the FCSC, forming a basal sister
to the remaining members of this complex (Fig. 2; only the MP
tree is shown). Analyses of the individual and combined data
sets support the recognition of four genealogically exclusive,
phylogenetically distinct species within this complex (Fig. 2).
Three of the four FCSC species were associated with mycotic
infections. However, because it is unclear which of these spe-
cies, if any, represents F. chlamydosporum, herein these three
species are designated FCSC 1, 2, and 3. High allelic diversity
was observed, with 12 STs among 13 isolates within FCSC 1
and four STs among 9 isolates within FCSC 2. The latter
species contained the most common ST sampled, FCSC 2-a,
with human isolates from Texas and Pennsylvania and a soil
isolate from Australia (Table 2). Lastly, the DNA typing re-
sults revealed that three of the four FCSC species exhibited
transoceanic distributions (FCSC 1, 2, and 4 [equivalent, F.
nelsonii]). Overall the FCSC four-locus typing scheme
TABLE 1—Continued
NRRL no. FIESC MLST(species)a Equivalent no(s).
b Isolate source Origin
36448 2-b CBS 384.92 Phaseolus vulgaris seed Sudan
36466 14-a (F. equiseti) CBS 414.86 Potato peel Denmark
36478 9-a (F. scirpi) CBS 447.84 Pasture soil Australia
36548 17-b CBS 190.60 Banana Congo
36575 20-b CBS 976.97 Juniperus chinensis leaf Hawaii
43297 24-b W. Elmer 22 Spartina rhizomes Connecticut
43498 8-b CDC 2006743466 Human eye Pennsylvania
43619 15-a UTHSC 05-2847 Human finger Texas
43622 15-c UTHSC 03-2501 Human lung Texas
43623 5-e UTHSC 03-59 Human maxillary sinus Colorado
43635 13-a UTHSC 06-638 Horse Nebraska
43636 14-c (F. equiseti) UTHSC 06-170 Dog Texas
43637 1-a UTHSC 05-1729 Dog Pennsylvania
43638 6-a UTHSC R-3500 Manatee Florida
43639 19-a UTHSC 04-135 Manatee Florida
43640 1-a UTHSC 04-123 Dog nose Texas
43694 6-a CDC 2006743607 Human eye Texas
43730 16-c CDC 2006743605 Contact lens Mississippi
45995 5-b UTHSC 02-966 Human abscess Colorado
45996 1-a UTHSC 03-3101 Human sinus New York
45997 5-f UTHSC 04-1902 Human sinus Colorado
45998 6-b UTHSC 06-2315 Human toe Texas
a Arabic numerals identify species, and lowercase roman letters identify unique haplotypes within each species.
b Sequences of F. concolor NRRL 13459 were used to root the phylogeny (Fig. 1).
c ATCC, American Type Culture Collection, Manassas, VA; BBA, Biologische Bundesanstalt fu¨r Land-und Forstwirtschaft, Institute fu¨r Mikrobiologie, Berlin,
Germany; CBS, CBS-KNAW Fungal Biodiversity Center, Utrecht, The Netherlands; CDC, Centers for Disease Control and Prevention, Atlanta, GA; Loyola, Loyola
University, Maywood, IL; IMI, CABI Biosciences, Egham, Surrey, England; MDA, M. D. Anderson Cancer Center, Houston, TX; WE, Wade Elmer, Connecticut
Agricultural Experiment Station, New Haven, CT.
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achieved an index of discrimination of 0.966 employing Simp-
son’s index of diversity (18).
Five novel Fusarium species causing mycotic infections. Six
isolates tentatively identified morphologically as members of
the FIESC or FCSC were resolved as five phylogenetically
distinct species nested outside these complexes, based on com-
parisons of partial EF-1 sequences with the FUSARIUM-ID
database (12) and partial RPB2 gene sequences from a more
TABLE 2. FCSC and novel pathogenic isolates subjected to DNA MLST
NRRL no. MLST and/or speciesa Equivalent no.c Isolate source Origin
13338 FCSC 4-a (F. nelsonii) FRC R-2181 Soil Australia
13444 FCSC 2-a FRC T-550 Corn soil Australia
13459 F. concolorb CBS 691.87 Plant debris South Africa
28505 FCSC 4-b (F. nelsonii) FRC R-8670 Soil debris South Africa
28578 FCSC 1-a CBS 615.87 Colocasia esculenta leaf Cuba
32521 FCSC 1-e FRC T-0852 Human cancer patient Texas
34012 FCSC 1-g UTHSC 01-451 Human toe Texas
34013 FCSC 2-a UTHSC 01-2416 Human toenail Pennsylvania
34014 FCSC 1-l UTHSC 01-2668 Human maxillary sinus Illinois
34015 FCSC 2-b UTHSC 02-1276 Horse eye Alabama
34016 FCSC 2-a UTHSC 98-2537 Human leg Texas
34017 FCSC 1-h UTHSC 97-59 Human maxillary sinus Texas
34018 FCSC 1-m UTHSC 97-17 Human arm Florida
34019 FCSC 1-c UTHSC 96-2036 Human eye Texas
34021 FCSC 2-a UTHSC 95-1488 Human upper lobe wash Texas
34022 FCSC 1-j UTHSC 93-2120 Human paranasal sinus Georgia
34023 FCSC 2-c UTHSC 93-1353 Human finger Texas
34033 F. brachygibbosum UTHSC 97-99 Human foot cellulites Texas
34036 Fusarium sp. strain 1, FTSC UTHSC 01-1965 Human ethmoid sinus Colorado
36147 Fusarium sp. strain 2, FTSC CBS 109232 Human bronchial secretion Unknown
36495 FCSC 2-b CBS 491.77 Soil Kuwait
36539 FCSC 1-k CBS 677.77 Cultivated soil Solomon Islands
43627 FCSC 2-d UTHSC 05-3559 Human bronchial lavage Texas
43628 FCSC 1-i UTHSC 05-3396 Human finger Florida
43629 FCSC 1-b UTHSC 05-3200 Human blood Utah
43630 FCSC 2-a UTHSC 05-2743 Human sputum Texas
43631 FCSC 3-a UTHSC 05-2441 Human leg Texas
43632 FCSC 1-d UTHSC 05-1260 Human eye Florida
43633 FCSC 1-f UTHSC 03-3472 Human maxillary sinus Tennessee
43641 F. armeniacum UTHSC 06-1377 Horse eye Missouri
45992 FCSC 1-j UTHSC 06-3823 Human leg South Carolina
45994 Fusarium sp. strain 2, FTSC UTHSC 06-2616 Cloaca Texas
45999 F. flocciferum UTHSC 06-3449 Human scalp California
a MLST within FCSC. Arabic numerals designate species, and lowercase roman letters identify unique haplotypes within each species.
b Sequences of F. concolor NRRL 13459 were used to root the phylogeny (Fig. 2).
c CBS, CBS-KNAW Fungal Biodiversity Center, Utrecht, The Netherlands; CDC, Centers for Disease Control and Prevention, Atlanta, GA.
TABLE 3. FIESC tree statistics for the individual and combined partitions
Locus Size(bp)
No. of
PICs
No. of
PICs/bp AUT
a MPT length
(no. of steps)b CI
c RId No. ofhaplotypese
No. of FIESC
species
supported as
monophyleticf
EF-1- 717 162 0.23 95 517 0.61 0.92 51 20
LSUITS rRNA genes 1,135 11 0.01 35 58 0.57 0.92 21 1
RPB2 1,766 220 0.12 184 629 0.58 0.92 46 19
CAM 704 133 0.19 109 385 0.64 0.94 45 14
EF-1- plus rRNA genes 1,852 173 0.09 130 602 0.57 0.91 59 —
EF-1- plus RPB2 2,483 382 0.15 279 1,181 0.57 0.91 57 —
EF-1- plus CAM 1,421 295 0.21 204 934 0.59 0.92 54 —
rRNA genes plus RPB2 2,901 231 0.08 219 714 0.55 0.91 54 —
rRNA genes plus CAM 1,839 144 0.08 144 469 0.58 0.93 56 —
RPB2 plus CAM 2,470 353 0.14 293 1,062 0.69 0.92 53 —
Combined 4,322 526 0.12 423 1,695 0.67 0.91 62 21
a AUT, autapomorphy or a derived character.
b MPT, most parsimonious tree.
c CI, consistency index.
d RI, retention index.
e Number of multilocus haplotypes or STs determined using COLLAPSE, version 1.1.
f Based on maximum parsimony bootstrap support. —, comparison not made.
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inclusive data set (K. O’Donnell, unpublished data). Results of
these analyses identified three isolates as described species:
NRRL 34033 (from human foot cellulites; Texas) was identi-
fied as F. brachygibbosum by comparison with the ex-type strain
NRRL 20954 ( BBA 64691); NRRL 43641 (from horse eye;
Missouri) as F. armeniacum by comparison with the ex-type
strain NRRL 26908 (CBS 485.94 and FRC R-9372); and
NRRL 45999 (from human scalp; California) formed a gene-
alogically exclusive group with F. flocciferum isolates NRRL
25471 (CBS 792.70 and BBA 11141) and NRRL 25473 (BBA
64346). The first two species are members of the trichothecene
toxin-producing clade of fusaria (21). NRRL 45999 F. floc-
ciferum, together with the remaining two clinical species, rep-
resented by NRRL 34036 Fusarium sp. strain 1 (from human
ethmoid sinus; Colorado) and NRRL 36147 Fusarium sp.
strain 2 (from human bronchial secretion; geographic origin
unknown), and NRRL 45994 Fusarium sp. strain 2 (from clo-
aca; Texas), are members of a clade designated herein as the F.
tricinctum species complex (FTSC) (21). NRRL 34036 Fusar-
ium sp. strain 1 (from human ethmoid sinus; Colorado) and
Fusarium sp. strain 2, represented by NRRL 36147 strain 1
(from human bronchial secretion; geographic origin unknown)
and NRRL 45994 strain 2 (from cloaca; Texas), appear to
represent two undescribed phylogenetically distinct species. To
our knowledge, the current study represents the first report
implicating these five species in causing mycotic infections of
humans and other animals.
DISCUSSION
Species limits and evolutionary relationships within two
closely related fusaria lineages, the FIESC and FCSC, together
with five clinically novel Fusarium species that are important in
medical and veterinary contexts, were investigated for the first
time employing multilocus GCPSR (49). The major finding of
the present study is that the FCSC and FIESC appear to
comprise, respectively, 4 and 28 phylogenetically distinct spe-
cies; that over 70% of the species within these two complexes
are represented by isolates recovered from infections of hu-
mans or other animals; and that they comprise approximately
15% of all fusarial infections within the United States. The 3
species within the FCSC and all 21 species within the FIESC
represented by two or more isolates fulfilled the highly con-
servative requirements of GCPSR as applied here in that they
were resolved as genealogically exclusive in the majority of the
four bootstrapped single-locus genealogies (37, 40). In addi-
tion, bootstrapping revealed that none of the individual gene-
alogies contradicted the monophyly of these species (i.e., ge-
nealogical nondiscordance sensu Dettman et al.) (10).
Additional sampling of more isolates is needed to assess the
monophyly of one putative species within the FCSC and seven
within the FIESC, given that they were each represented by a
single genetically divergent isolate in the present study.
Phylogenetic diversity of FIESC clinical isolates. This study
describes the first MLST typing scheme for species and hap-
FIG. 1. One of 12 most-parsimonious trees inferred from MP analysis of the combined four-locus data set for 88 isolates within the FIESC. The
phylogram is rooted by the outgroup method using sequences of F. concolor NRRL 13459. Arabic numbers and lowercase Roman letters identify
species and their multilocus STs, respectively. Human and veterinary isolates are distinguished from nonclinical isolates by shading. Veterinary
isolates are distinguished from those from humans by a solid dot to the right of the NRRL number/ST. In addition, a star to the right of ST 6-a
indicates that one isolate was from a veterinary source and the other from a human. Note that Latin binomials can be applied confidently to only
3 of 14 species within the Equiseti clade and to none of the species within the Incarnatum clade. MP bootstrap values based on 1,000
pseudoreplicates of the data are indicated above internodes. ML bootstrap values are indicated below internodes only when they differed by 5%
of the MP value.
TABLE 4. FCSC tree statistics for the individual and combined partitions
Locus Size(bp)
No. of
PICs
No. of
PICs/bp AUT
a MPT length
(no. of steps)b CI
c RId No. ofhaplotypese
No. of FCSC
species
supported as
monophyleticf
EF-1- 710 159 0.22 74 379 0.81 0.89 17 (7) 3
LSUITS rRNA genes 1,153 69 0.06 45 156 0.85 0.9 14 (6) 2
RPB2 1,766 335 0.19 111 697 0.71 0.88 17 (7) 3
CAM 670 177 0.26 59 364 0.82 0.88 12 (5) 2
EF-1- plus rRNA genes 1,863 228 0.12 119 551 0.73 0.87 24 (7) —
EF-1- plus RPB2 2,476 494 0.2 185 1,084 0.72 0.88 23 (7) —
EF-1- plus CAM 1,380 336 0.24 133 745 0.77 0.88 21 (7) —
rRNA genes plus RPB2 2,919 404 0.14 156 872 0.71 0.87 21 (7) —
rRNA genes plus CAM 1,823 246 0.13 104 540 0.8 0.86 20 (6) —
RPB2 plus CAM 2,436 512 0.21 170 1,065 0.78 0.88 21 (7) —
Combined 4,299 740 0.17 289 1,627 0.78 0.87 27 (7) 3
a AUT, autapomorphy or a derived character.
b MPT, most parsimonious tree.
c CI, consistency index.
d RI, retention index.
e Number of multilocus haplotypes or STs determined using COLLAPSE, version 1.1. Note that the number in parentheses refers to the number of STs for the
non-FCSC isolates within the ingroup.
f Based on maximum parsimony bootstrap support. —, comparison not made.
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lotypes based on nucleotide polymorphism within portions of
four nuclear genes among members of the FIESC that are
important in both clinical and veterinary contexts. Previous
molecular phylogenetic studies of the FIESC have not focused
on identifying GCPSR-based species limits among clinically
relevant or mycotoxigenic isolates, given that their genetic di-
versity was assessed only via partial DNA sequence data from
single nuclear genes such as EF-1 (21, 42), RPB2 (34), -tu-
bulin (3), 28S rDNA (15), or restriction fragment polymor-
phisms from the nuclear ribosomal intergenic spacer region
(rDNA) (20). Based on the results of the present study, EF-1
was the most phylogenetically informative gene and the
ITSLSU 28S rDNA was the least informative. Even though
the latter locus possessed relatively little phylogenetic signal,
the typing schemes benefited from its inclusion by an increase
of six STs within the FIESC and three STs within the FCSC.
One of the most surprising results to emerge from the
present study is that the species-rich FIESC comprises at least
20 mycoses-associated species among the 28 reciprocally
monophyletic lineages resolved by the multilocus molecular
phylogenetics. What makes this finding all the more remark-
able is that only one of the 52 clinical isolates was recovered
from outside the United States, revealing that phylogenetically
diverse human-opportunistic members of this complex are well
represented in North America. Moreover, phenotypically
based taxonomic treatments of the genus have underestimated
species diversity within the FIESC by close to 1 order of mag-
nitude (13, 22, 28). Similar GCPSR-based studies within other
clinically important clades within Fusarium, such as the FSSC
(30, 35, 51), GFSC (31, 33), FDSC (44), and FOSC (36) have
revealed similar levels of cryptic speciation.
The result is that Latin binomials can be applied with con-
fidence to only 3 of the 28 species within the FIESC (Fig. 1).
This is due primarily to the discovery of the large number of
phylogenetically distinct but morphologically cryptic species
reported herein and also to unresolved taxonomic and nomen-
clatural problems associated with applying validly published
names such as F. incarnatum and F. pallidoroseum and their
varieties (19, 46), which might represent phylogenetically dis-
tinct species, to members of the FIESC. Although the name F.
FIG. 2. One of 12 most-parsimonious MP phylograms inferred from the combined data from four loci for the FCSC and related clinically
relevant fusaria rooted with sequences of F. concolor NRRL 13459. Arabic numbers and lowercase Roman letters are used to identify four species
and their multilocus STs within the FCSC. Dark shading identifies isolates from human clinical and veterinary sources, the latter of which are
further distinguished by a solid dot to the right of the NRRL number/ST. A star to the right of Fusarium sp. strain 2 indicates that it was represented
by one human and one veterinary isolate. It is unclear which of the three unnamed species within the FCSC represents F. chlamydosporum, if any.
Numbers above nodes represent the frequency (percent) with which they were recovered from 1,000 MP bootstrap pseudoreplicates of the data.
ML bootstrap values are indicated only below those internodes that differed by5% of the MP value. The present study represents the first report
of the five species basal to the FCSC causing mycotic infections in humans and other animals. Fusarium brachygibbosum and F. armeniacum are
members of the trichothecene toxin-producing clade, whereas the other non-FCSC ingroup species are members of the FTSC.
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semitectum has been used in the literature more than any other
species within the Incarnatum clade, study of the type collec-
tion surprisingly revealed that this binomial has been misap-
plied because it is a later synonym of Colletotrichum musae (6).
These systematic problems are exacerbated by the dearth of
and homoplasious morphological characters within the FIESC
and because type specimens, where known, are too old for
DNA typing using the present four-locus MLST scheme.
In the absence of binomials for most of the species within
the FIESC, one of the primary objectives of the present study
was to extend the standardized multilocus species/haplotype
nomenclature, first proposed in the CDC’s keratitis outbreak
investigation (8), to each member of the FIESC to facilitate
communication of epidemiologically relevant data within the
public health, phytopathological, and mycotoxin research com-
munities. In this connection, it is worth mentioning that 59%
of the FIESC isolates typed represented unique STs, with
FIESC 15’s 16 isolates and five STs from Texas or Oklahoma
being the most common species sampled. This finding, how-
ever, undoubtedly represents a sampling bias given that close
to two-thirds of the clinically relevant isolates we typed were
obtained from the University of Texas Health Science Center’s
(UTHSC) Fungus Testing Laboratory in San Antonio, TX.
Clearly, future studies are needed to elucidate how clinically
relevant STs are distributed throughout North America and on
other continents with the aim of identifying their environmen-
tal reservoirs. Surveys of the FIESC in nature indicate that they
are common on phylogenetically diverse plants and plant de-
bris and in soil in both hemispheres (13). Moreover, members
of the Incarnatum clade are especially prevalent in the tropics
and subtropics (13). Because members of the FIESC have been
reported to produce type A and B trichothecene mycotoxins
(14, 17, 25), which can alter immune function (39) and inhibit
eukaryotic protein synthesis (50), as well as cytotoxic enniatins
(16, 24) and estrogenic mycotoxins (14, 17, 20, 25), studies are
needed to evaluate whether any of these toxins function as
virulence factors in animal pathogenesis. In addition, ongoing
studies are directed at investigating their mycotoxin potential
in vitro using the phylogenetic framework developed in the
present study.
Phylogenetic diversity of FCSC clinical isolates. Herein, we
report on the first MLST scheme for members of the FCSC.
This scheme was used to type 20 relevant isolates from clinical
or veterinary sources from the United States, employing por-
tions of the same four loci used for the FIESC. The discovery
of highly divergent -tubulin paralogs or xenologs, as in the
FIESC and FSSC (30), precluded the use of this locus for
phylogeny reconstruction in the present study. Even so, Azor
et al. (3) recently reported that phylogenetic analysis of a
378-bp portion of the -tubulin gene from eight isolates iden-
tified as F. chlamydosporum formed a weakly supported clade
(61% bootstrap), which suggests that orthologous alleles were
sampled. The only other published phylogenetic analysis of the
FCSC, which strongly supported its monophyly (100% boot-
strap), was conducted using a 1.8-kb portion of RPB2 (34), but
only four isolates were studied. Results of the present study
represent the first GCPSR-based assessment of species limits
within the FCSC. Species were recognized only if they were
reciprocally monophyletic in at least half of the individual
partitions and no genealogical discordance was observed (37,
40). Using these ranking criteria, three phylogenetically dis-
tinct, clinically relevant species were resolved within the mor-
photaxon F. chlamydosporum.
Given that the type specimen of this species was isolated
from banana in Honduras (13) and that isolates from this host
and/or geographic location were unavailable for study, it is
unclear which of the three FCSC species, if any, corresponds to
F. chlamydosporum. Because the type specimen of this species
was collected in 1925 and an ex-type strain does not exist, study
of isolates collected from banana at the type locality may help
resolve this taxonomic problem. The species/haplotype nomen-
clature originally developed by Chang et al. (8) for the fusaria
keratitis outbreak adopted in the present study, using Arabic
numbers for species and lowercase roman letters for each
unique ST, obviates these taxonomic issues and promotes pre-
cise communication of the MLST data within the scientific
community. Results of the present study, which show that the
two most common STs, FCSC 2-a and 2-b, exhibited intercon-
tinental distributions and were represented by soil isolates, is
consistent with reports that the broadly defined morphospecies
F. chlamydosporum is common in soils and the rhizosphere of
numerous vascular plants worldwide (13). Isolates of the
fourth species within the FCSC, F. nelsonii, have not been
reported to cause mycotic infections, possibly because they
have been recovered only from remote or sparsely populated
regions in South Africa (26) and Australia (this study) or
possibly because they may have been misidentified as F.
chlamydosporum or F. incarnatum. Given that the FCSC iso-
lates from humans and other animals included in the present
study were all from the United States, future studies are
needed to elucidate the global distribution of clinically impor-
tant species/STs, which should help identify their environmen-
tal reservoirs and identify widespread clones or clonal lineages
(36). Further, because members of the FCSC are able to elab-
orate several mycotoxins, including trichothecenes and monili-
formin (25), the phylogenetic framework developed in the
present study will be used to evaluate species/ST mycotoxin
potential to better understand the risk these strains pose to
food safety and human health (38).
Five novel Fusarium species causing mycotic infections. The
extremely homoplasious morphological characters within the
FIESC and FCSC contributed significantly to the initial phe-
notypic misidentifications of the five novel fusaria causing in-
fections of humans and other animals as F. equiseti, F. incar-
natum, or F. chlamydosporum. Fortunately, accurate molecular
identifications were easily obtained by simply comparing par-
tial EF-1 sequences with those in the FUSARIUM-ID data-
base (12) and/or molecular phylogenetic analysis of a compre-
hensive data set of partial RPB2 sequences for human
pathogenic and phytopathogenic fusaria (O’Donnell, unpub-
lished). Significant advantages of the molecular approach,
based on results of the present study, include that it can pro-
vide accurate identifications of rare and novel mycotic agents
that are named (i.e., F. brachygibbosum, F. flocciferum, and F.
armeniacum) as well as those that apparently lack Latin bino-
mials (i.e., Fusarium sp. strain 1 and Fusarium sp. strain 2). It
is worth mentioning that a third isolate of Fusarium sp. strain
2, NRRL 28032, was received from the CDC as B-4271 in 1998,
isolated from a toenail infection from a patient in Colorado.
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Conclusions and future directions. It is important that the
MLST schemes developed for the FIESC and FCSC in the
present study, in contrast to those available via the Internet for
some of the most important human pathogenic species (4, 23),
focused primarily on identifying species limits within these
closely related species complexes. Nevertheless, the four-locus
typing schemes for the FIESC and FCSC achieved indices of
discrimination of 0.985 and 0.966, respectively, using Simpson’s
index of diversity (18). Should the necessity arise, identification of
additional phylogenetically informative loci for the MLST
schemes will be greatly facilitated by four phylogenetically diverse
fusarial genomes that are available online, one representing the
FSSC from the Joint Genome Institute (http://www.jgi.doe.gov)
and three from the Broad Institute of Massachusetts Institute of
Technology and Harvard representing the FOSC, GFSC, and
the trichothecene toxin-producing fusaria (9; http://www.broad
.mit.edu/annotation/fungi/fgi/). With the development of
GCPSR-based MLST schemes for the six most important hu-
man-pathogenic species complexes within Fusarium (i.e.,
FSSC, FOSC, GFSC, FDSC, FIESC, and FCSC) (see Fig. 1 in
reference 34), which collectively comprise close to 100% of all
medically important isolates, a uniform finding that has
emerged from these studies is the dramatic discrepancy be-
tween species identifications using morphology alone versus
molecular phylogenetics. Results of the present study and
those published previously (34, 35, 51) have revealed that only
30% of clinically relevant fusaria (i.e., 20 of 65) have Latin
binomials that can be applied with confidence. This is largely
due to high levels of cryptic speciation and the concomitant
extreme morphological homoplasy, especially within the
FIESC and FSSC (30, 35, 51), as reflected by the fact that only
3 of the 21 FIESC and 3 of the 20 FSSC mycoses-associated
species have known scientific names. In the absence for mor-
phological apomorphies, the MLST schemes provide the only
means by which isolates can be identified to species/haplotype
with confidence and be accurately reported on in the scientific
literature. Because species limits were delimited within the
FIESC and FCSC for the first time in the present study, it is
possible for us to recommend using a partial EF-1 gene se-
quence for identifying species within these two complexes.
With the present set of isolates, sequence data from this locus
was used to identify all 28 species within the FIESC and all 4
species within the FCSC. However, as putatively novel species
are detected, GCPSR-based studies will be required to fully
assess their genealogical exclusivity. It is worth mentioning that
matrix-assisted laser desorption ionization–time of flight anal-
ysis appears to provide a potential avenue for rapidly identi-
fying clinical fusaria to the level of species complex (27) or in
some cases to species level, assuming their boundaries have
been defined previously by GCPSR. In this preliminary study,
35 of the 62 isolates analyzed were identified to one of three
species complexes, with only isolates of F. verticillioides and F.
proliferatum being identified to species. Even though these
results are encouraging, it remains to be determined whether
matrix-assisted laser desorption ionization–time of flight anal-
ysis can be used to identify most or all of the approximately 65
clinically relevant fusaria to the species level.
To further promote identification of pathogenic fusaria, In-
ternet-accessible standardized MLST databases of clinically
relevant fusaria will be made available at the CBS and the
FUSARIUM-ID website (http://fcgp.fusariumdb.org/) at Pennsyl-
vania State University. These databases will be updated regu-
larly as new species/STs are discovered, contingent on the
deposit of associated chromatograms, which are essential to
ensure that sequences are error free, and of cultures in an
international, publically accessible culture collection to pro-
mote further study by the scientific community. The MLST
databases should be viewed as a work in progress (48), provid-
ing a novel baseline for understanding Fusarium population
biology and potential changes in the spectrum of clinically
relevant fusaria within a robust phylogenetic framework.
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